Live Breaking News & Updates on Prior Lines Of Therapy

Stay updated with breaking news from Prior lines of therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Key Considerations in Treatment Selection for Patients With Multiple Myeloma

Experts describe considerations for selecting appropriate patients for treatment with a bispecific antibody, including prior therapies for relapsed or refractory multiple myeloma. Strategies to quickly prepare patients for treatment with a bispecific antibody are also discussed. ....

Anthony Perissinotti , Ryan Haumschild , Matthew Pianko , Practice Pearls , Prior Lines Of Therapy , Relapsed Refractory Multiple Myeloma , Bispecific Antibodies , Adverse Event Profile , Immune Effector Cell Associated Neurotoxicity Syndrome , Cytotoxic Chemotherapy , Cart Cell ,